Moji Awogbade

1.3k total citations
29 papers, 687 citations indexed

About

Moji Awogbade is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Moji Awogbade has authored 29 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 17 papers in Hematology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Moji Awogbade's work include Hemoglobinopathies and Related Disorders (27 papers), Iron Metabolism and Disorders (13 papers) and Prenatal Screening and Diagnostics (9 papers). Moji Awogbade is often cited by papers focused on Hemoglobinopathies and Related Disorders (27 papers), Iron Metabolism and Disorders (13 papers) and Prenatal Screening and Diagnostics (9 papers). Moji Awogbade collaborates with scholars based in United Kingdom, United States and Norway. Moji Awogbade's co-authors include Jo Howard, Swee Lay Thein, Michelle Cummins, Bernard A. Davis, Nicholas Hart, Nisha Vasavda, Marlene Allman, Emma Drašar, David C. Rees and A. D. Stephens and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Moji Awogbade

29 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moji Awogbade United Kingdom 15 607 466 205 68 59 29 687
Miranda Athanassiou‐Metaxa Greece 15 424 0.7× 402 0.9× 109 0.5× 39 0.6× 37 0.6× 29 587
Beatrice E. Gee United States 12 886 1.5× 759 1.6× 190 0.9× 108 1.6× 127 2.2× 36 1000
Ioanna Tsatra Greece 14 437 0.7× 421 0.9× 104 0.5× 35 0.5× 15 0.3× 26 550
Alessia Marcon Italy 13 333 0.5× 273 0.6× 80 0.4× 43 0.6× 20 0.3× 32 416
Beatrice Files United States 9 396 0.7× 347 0.7× 137 0.7× 50 0.7× 37 0.6× 15 464
Brown Ak United States 7 511 0.8× 434 0.9× 235 1.1× 48 0.7× 41 0.7× 13 641
Alexandra Stamoulakatou Greece 18 717 1.2× 656 1.4× 139 0.7× 144 2.1× 83 1.4× 44 901
Marianne E. Yee United States 13 302 0.5× 316 0.7× 57 0.3× 138 2.0× 28 0.5× 40 425
Rayan Bou‐Fakhredin Lebanon 15 397 0.7× 338 0.7× 69 0.3× 78 1.1× 63 1.1× 41 538
Charles Knupp United States 12 152 0.3× 241 0.5× 17 0.1× 28 0.4× 51 0.9× 28 414

Countries citing papers authored by Moji Awogbade

Since Specialization
Citations

This map shows the geographic impact of Moji Awogbade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moji Awogbade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moji Awogbade more than expected).

Fields of papers citing papers by Moji Awogbade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moji Awogbade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moji Awogbade. The network helps show where Moji Awogbade may publish in the future.

Co-authorship network of co-authors of Moji Awogbade

This figure shows the co-authorship network connecting the top 25 collaborators of Moji Awogbade. A scholar is included among the top collaborators of Moji Awogbade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moji Awogbade. Moji Awogbade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oteng‐Ntim, Eugene, Laura Oakley, Vicky Robinson, et al.. (2024). Prophylactic exchange transfusion in sickle cell disease pregnancy: a TAPS2 feasibility randomized controlled trial. Blood Advances. 8(16). 4359–4369. 6 indexed citations
2.
Clayden, Jonathan D., Jamie M. Kawadler, April Slee, et al.. (2022). Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia. Blood Advances. 7(11). 2297–2308. 7 indexed citations
3.
Hood, Anna, Jamie M. Kawadler, April Slee, et al.. (2021). Biopsychosocial Predictors of Quality of Life in Paediatric Patients With Sickle Cell Disease. Frontiers in Psychology. 12. 681137–681137. 15 indexed citations
4.
Willis, Joanna, Moji Awogbade, Jo Howard, et al.. (2020). Outcomes following kidney transplantation in patients with sickle cell disease: The impact of automated exchange blood transfusion. PLoS ONE. 15(8). e0236998–e0236998. 11 indexed citations
5.
Oakley, Laura, Moji Awogbade, Sarah Brien, et al.. (2020). Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial. Trials. 21(1). 347–347. 13 indexed citations
6.
Howard, Jo, Claire Hemmaway, Paul Telfer, et al.. (2019). A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease. Blood. 133(17). 1865–1875. 84 indexed citations
7.
Farook, Mohamed, et al.. (2018). Total hip arthroplasty in osteonecrosis secondary to sickle cell disease. International Orthopaedics. 43(2). 293–298. 23 indexed citations
8.
Howard, Jo, Claire Hemmaway, Moji Awogbade, et al.. (2016). Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor. Blood. 128(22). 2488–2488. 11 indexed citations
9.
10.
Gardner, Kate, Abdel Douiri, Marlene Allman, et al.. (2015). Survival in Sickle Cell Disease: Data from a Well-Resourced, National Health System Setting. Blood. 126(23). 71–71. 2 indexed citations
11.
Drašar, Emma, Nisha Vasavda, Matthew Free, et al.. (2011). Blood transfusion usage among adults with sickle cell disease – a single institution experience over ten years. British Journal of Haematology. 152(6). 766–770. 51 indexed citations
12.
Drašar, Emma, Nisha Vasavda, Moji Awogbade, et al.. (2010). BLOOD TRANSFUSION USAGE AMONG PATIENTS WITH SICKLE CELL DISEASE - A SINGLE INSTITUTION EXPERIENCE OVER TEN YEARS. Haematologica. 95. 205–205. 4 indexed citations
13.
Gardner, Kate, Jack Bartram, Marlene Allman, et al.. (2010). Outcome of adults with sickle cell disease admitted to critical care – experience of a single institution in the UK. British Journal of Haematology. 150(5). 610–613. 23 indexed citations
14.
Quek, Lynn, Claire C. Sharpe, Neelanjana Dutt, et al.. (2010). Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease. British Journal of Haematology. 149(2). 289–291. 9 indexed citations
15.
Yu, C. K. H., et al.. (2009). Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic. Journal of Obstetrics and Gynaecology. 29(6). 512–516. 28 indexed citations
16.
Ulug, Pinar, Nisha Vasavda, Rohan Kumar, et al.. (2008). Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemia. American Journal of Hematology. 83(9). 714–716. 7 indexed citations
17.
Vasavda, Nisha, Stephan Menzel, Moji Awogbade, et al.. (2007). The linear effects of α‐thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. British Journal of Haematology. 138(2). 263–270. 58 indexed citations
18.
Sylvester, Karl, Sujal R. Desai, Athol U. Wells, et al.. (2006). Computed tomography and pulmonary function abnormalities in sickle cell disease. European Respiratory Journal. 28(4). 832–838. 18 indexed citations
19.
Dalton, R. Neil, Charles Turner, Moira Dick, et al.. (2005). The measurement of urinary hydroxyurea in sickle cell anaemia. British Journal of Haematology. 130(1). 138–144. 14 indexed citations
20.
Westwood, Mark A., et al.. (2004). Myocardial biopsy and T2* magnetic resonance in heart failure due to thalassaemia. British Journal of Haematology. 128(1). 2–2. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miranda Athanassiou‐Metaxa Breakdown of academic impact, for papers by Beatrice E. Gee Breakdown of academic impact, for papers by Ioanna Tsatra Breakdown of academic impact, for papers by Alessia Marcon Breakdown of academic impact, for papers by Beatrice Files Breakdown of academic impact, for papers by Brown Ak Breakdown of academic impact, for papers by Alexandra Stamoulakatou Breakdown of academic impact, for papers by Marianne E. Yee Breakdown of academic impact, for papers by Rayan Bou‐Fakhredin Breakdown of academic impact, for papers by Charles Knupp
Rankless by CCL
2026